Press Releases

Personal HealthKey™ Becomes Integral Component In Training For Future Health Care Professionals At The College Of St. Scholastica

NEWTOWN, PA – March 7, 2005 -- Bio-Imaging Technologies, Inc. (NASDAQ NMS: BITI) announced today that its CapMed division has customized its Personal HealthKey™ product to The College of St. Scholastica in Duluth, Minnesota, to be used as part of the training for students in the Healthcare Informatics and Information Management Department.

Students at St. Scholastica who are majoring in Health Information Management are learning about the proposed National Health Information Infrastructure (NHII), of which personal health management is a core component, while gaining hands-on experience managing their health with their Personal HealthKey. The St. Scholastica Personal HealthKey will be used to educate these future healthcare professionals about personal health records, the important role the patient plays in health information management, and how personal health records can help them to manage their own health. The Personal HealthKey includes direct links to St. Scholastica’s student resources such as their health and wellness center.

Wendy Angst, general manager of CapMed said, “We are excited to work with St. Scholastica to support a ground-breaking program to educate university-level students about healthcare technology. These students represent the future of healthcare, and through programs such as this, students are learning first hand about the importance of electronic medical records and the critical component that personal health records play in that process.”

Vicki Zeman, faculty in the Healthcare Informatics and Information management Department, and Kathleen Thiede, faculty in the Nursing Department are coordinating the Personal HealthKey project. The College of St. Scholastica received a grant funded by the Minnesota Community Foundation called: A Vision for Healthcare: Taking Personal Responsibility. Through this grant St. Scholastica has customized the CapMed Personal HealthKey and plans to research the outcomes of students using the HealthKey to manage their health and wellness when they commute between home and campus.

Professor Zeman explained, “By working with the Personal HealthKey we are empowering our students to track and manage their health as well as learn about the progression of health information technology. We strive to teach our students with the latest technologies to prepare them in the ever changing healthcare arena. ”

Tracy Swanson, a senior in the Health Information Management curriculum department, said, “The students working with the Personal HealthKey this semester are excited to learn about personal health records and by each of us having our own HealthKey it allows us to gain hands-on experience. ”

St. Scholastica will be offering the HealthKey to nursing students in May 2005 and to occupational therapy, physical therapy and exercise physiology students in the Fall of 2005.

About Bio-Imaging

Bio-Imaging Technologies, Inc. is a healthcare contract service organization providing services that support the product development process of the pharmaceutical, biotechnology and medical device industries. The Company has specialized in assisting its clients in the design and management of the medical-imaging component of clinical trials since 1990. Bio-Imaging serves its clients on a global basis through its US Core Lab (Newtown PA), European Core Lab (Leiden, The Netherlands) and U.S. Business Offices (Massachusetts and California). Through its recently acquired CapMed division, Bio-Imaging provides the Personal HealthKey™ technology and the Personal Health Record™ (PHR) software allowing patients to better monitor and manage their health care information.

Certain matters discussed in this press release are "forward-looking statements" intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company's statements regarding trends in the marketplace and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the timing of projects due to the variability in size, scope and duration of projects, estimates made by management with respect to the Company's critical accounting policies, regulatory delays, clinical study results which lead to reductions or cancellations of projects, and other factors, including general economic conditions and regulatory developments, not within the Company's control. The factors discussed herein and expressed from time to time in the Company's filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward-looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.